(Total Views: 418)
Posted On: 12/30/2020 10:50:57 PM
Post# of 153964
eIND and Extension of s/c Trial enrollment w/o Placebo.
Taken from the Dec 24th PR:
The CD12 protocol will be amended for adding the open-label arm extension and submitted to the FDA on Monday, December 28, 2020.
One could read the PR to be saying that the eIND "continuation" is just being continued, no new guidelines to be met, just reactivated immediately????
Taken from the Dec 24th PR:
The CD12 protocol will be amended for adding the open-label arm extension and submitted to the FDA on Monday, December 28, 2020.
One could read the PR to be saying that the eIND "continuation" is just being continued, no new guidelines to be met, just reactivated immediately????
(1)
(0)
